HCP5 (HLA complex P5) is dysregulated in a wide variety of cancers and diseases such as osteosarcoma [64], cervical cancer [65], and glioma [66] as well as psoriasis [67] and kawasaki disease [68]. Here, HCP5 is linked to glioma.